- Patent Title: Agent acting on transcellular ion transporter in intestinal tract, agent for activating chloride channel, agent for preventing or treating renal disease, or agent for promoting defecation
-
Application No.: US16343696Application Date: 2017-10-18
-
Publication No.: US11376287B2Publication Date: 2022-07-05
- Inventor: Ayako Maeda , Masaki Shimakawa , Hiroshi Ohno
- Applicant: Biofermin Pharmaceutical Co., Ltd.
- Applicant Address: JP Kobe
- Assignee: Biofermin Pharmaceutical Co., Ltd.
- Current Assignee: Biofermin Pharmaceutical Co., Ltd.
- Current Assignee Address: JP Kobe
- Agency: Knobbe, Martens, Olson & Bear, LLP
- Priority: JPJP2016-206422 20161020
- International Application: PCT/JP2017/037698 WO 20171018
- International Announcement: WO2018/074514 WO 20180426
- Main IPC: A61K35/745
- IPC: A61K35/745 ; A61P1/10 ; A61P13/12 ; A61K35/747 ; C12N1/20

Abstract:
Provided is an agent having an action on a transcellular ion transporter in the intestinal tract, the agent containing a bacterium of the genus Bifidobacterium or the genus Lactobacillus, or a treated product thereof, with the proviso that the case where the ion transporter is a chloride channel and the action is inhibition; the case where the ion transporter is Na+K+Cl− cotransporter (NKCC1) and the action is inhibition; the case where the bacterium is Bifidobacterium infantis 35624; and the case where the bacterium is Lactobacillus salivarius UCC118 are excluded. The agent of the present invention is useful in activation of chloride channels, prevention or treatment of renal diseases, and/or promotion of defecation, and therefore, usable as a medicament, a supplement, etc.
Public/Granted literature
Information query
IPC分类: